Intratumoral core microbiota predicts prognosis and therapeutic response in gastrointestinal cancers
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.00390-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Jia Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department …. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Microbiota, Bacteria, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for Central Universities of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Microbial communities residing in tumors constitute a critical component of the tumor microenvironment, particularly in gastrointestinal cancers arising from mucosal sites. However, the relationship between microbiota and oncogenesis, as well as its clinical applications, remains underexplored. Here, we performed a comprehensive analysis of the tumor microbiome across six gastrointestinal cancer types and identified a core microbiota composed of 15 bacterial genera associated with patient prognosis. Using bacterial abundance data, we developed a microbiota-based prognostic model to calculate a “risk score.” Patients with high-risk scores exhibited poorer prognosis and increased metastatic potential, driven by the activation of tumor metastasis-related signaling pathways, including epithelial-mesenchymal transition, angiogenesis, KRAS, and TGFβ signaling. Furthermore, the model predicted sensitivity to anti-cancer drugs, identifying XL999 and tandutinib as potential targeted therapies for high-risk patients. The core microbiota is also linked to host immunity; patients with high-risk scores were less likely to benefit from immunotherapy. Taken together, these findings highlight the potential of a microbiota-based prognostic model to enhance cancer diagnostics, inform therapeutic decision-making, and advance personalized medicine for gastrointestinal cancers. IMPORTANCE Intratumoral microbiota influence cancer progression, yet their prognostic potential remains underutilized. This study identifies a core microbiota of 15 bacterial genera associated with survival in gastrointestinal cancers and develops a microbiota-based prognostic model. Unlike traditional gene-based models, this approach stratifies patients by microbial signatures, linking high-risk scores to enhanced metastasis via epithelial-mesenchymal transition, angiogenesis, and KRAS signaling. Additionally, we identify XL999 and tandutinib as potential therapies for high-risk patients and reveal that microbiota composition correlates with immunotherapy response. By integrating microbiome profiling into cancer prognosis and treatment selection, this study offers a novel strategy for precision oncology, advancing microbial biomarkers for risk assessment, drug selection, and personalized immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, Frontiers Science Center for Cell Responses, College…
- College of Biotechnology, Tianjin University of Science and Technology, Tianjin, China.
ORCID-Profile: Jia Liu, Yue Chen, Xingzhong Liu
Förderung
- Fundamental Research Funds for Central Universities of China
- National Natural Science Foundation of China
Zitieren
APA
Liu, J., Wei, D., Chen, Y., & Liu, X. (2025). Intratumoral core microbiota predicts prognosis and therapeutic response in gastrointestinal cancers. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00390-25
Vancouver
Liu J, Wei D, Chen Y, Liu X. Intratumoral core microbiota predicts prognosis and therapeutic response in gastrointestinal cancers. Microbiology Spectrum. 2025. doi:10.1128/spectrum.00390-25
BibTeX
@article{Liu2025,
author = {Liu, Jia and Wei, Dongsheng and Chen, Yue and Liu, Xingzhong},
title = {Intratumoral core microbiota predicts prognosis and therapeutic response in gastrointestinal cancers},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.00390-25}
}
EUVIMED